Nusano
  • Company
    • Leadership
    • Mission & Values
    • West Valley City
    • Contact Us
  • Technology
  • Batteries
  • Energy
    • HALEU
    • Nuclear Fuel Cycle
  • Industrial
  • Life Sciences
    • Medical Isotopes
    • Request Quote
    • R&D Collaboration
    • Advisory Board
    • About Nuclear Med
  • News
    • Press Releases
    • Video
    • Podcast
    • Email Sign Up
  • Careers
    • Current Openings
    • Life in Utah
Select Page
Nusano and PharmaLogic Announce Strategic Supply Agreement to Enable Current and Emerging Radiopharmaceuticals

Nusano and PharmaLogic Announce Strategic Supply Agreement to Enable Current and Emerging Radiopharmaceuticals

by Scott Larrivee | Jul 10, 2024 | News

VALENCIA, Calif. and BOCA RATON, Fla. – July 10, 2024 – Nusano Inc. (Nusano), a physics company transforming the production of medical radioisotopes, and PharmaLogic Holdings Corp. (PharmaLogic), a leading radiopharmaceutical contract development and manufacturing...
Next Entries »

Recent Posts

  • Nusano Achieves Key Technology Milestone Enabling Simultaneous Production of Multiple Radioisotopes
  • Talk Radioisotopes: Paul Schrimpf, Proprietor & Entrepreneur, Cyrall
  • Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply Agreement
  • Nusano CEO Chris Lowe on Connor Group Podcast
  • dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply

Recent Comments

No comments to show.
Nusano
Supplying the fight against cancer & enabling life-changing innovations
  • Follow
  • Follow
  • Follow
Company
about us
Leadership
Contact us
technology

The Nusano Platform
R&D Collaboration

Resources
News
Careers
Suppliers
© 2025 Nusano | Web design
Privacy Policy – Terms of Service